131 related articles for article (PubMed ID: 14626572)
1. The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation.
Lietz K; Lao M; Paczek L; Górski A; Gaciong Z
Ann Transplant; 2003; 8(2):17-24. PubMed ID: 14626572
[TBL] [Abstract][Full Text] [Related]
2. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
[TBL] [Abstract][Full Text] [Related]
3. Effect of pretransplant erythropoietin therapy on renal allograft outcome.
Vasquez EM; Pollak R
Transplantation; 1996 Oct; 62(7):1026-8. PubMed ID: 8878400
[TBL] [Abstract][Full Text] [Related]
4. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
Trkulja V
Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group.
Biggs JC; Atkinson KA; Booker V; Concannon A; Dart GW; Dodds A; Downs K; Szer J; Turner J; Worthington R
Bone Marrow Transplant; 1995 Jan; 15(1):129-34. PubMed ID: 7742745
[TBL] [Abstract][Full Text] [Related]
6. The effect of erythropoietin and blood transfusions on highly sensitized patients on a single cadaver renal allograft waiting list.
Deierhoi MH; Barger BO; Hudson SL; Shroyer TW; Diethelm AG
Transplantation; 1992 Feb; 53(2):363-8. PubMed ID: 1738931
[TBL] [Abstract][Full Text] [Related]
7. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Przegl Lek; 1995; 52(12):590-3. PubMed ID: 8834657
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Khan I; Rabindranath K; Vale L; Wallace S; Macleod A
Cochrane Database Syst Rev; 2005 Jul; (3):CD003266. PubMed ID: 16034896
[TBL] [Abstract][Full Text] [Related]
9. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
Kerman RH; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
Nampoory MR; Johny KV; al-Hilali N; Seshadri MS; Kanagasabhapathy AS
Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
Sinnassamy P; Andre JL; Treize G; Leroy B
Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
[TBL] [Abstract][Full Text] [Related]
12. [Chemical structure, biotechnical production and clinical use of recombinant erythropoietin].
Fandrey JK; Jelkmann WE
Z Gesamte Inn Med; 1992 Jun; 47(6):231-8. PubMed ID: 1642021
[TBL] [Abstract][Full Text] [Related]
13. [Erythropoietin--physiology and therapeutic potentialities].
Möllmann M
Anasthesiol Intensivmed Notfallmed Schmerzther; 1992 Dec; 27(8):461-8. PubMed ID: 1489869
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin and erythropoiesis in renal transplantation.
Kessler M
Nephrol Dial Transplant; 1995; 10 Suppl 6():114-6. PubMed ID: 8524479
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant human erythropoietin as an antianemic and performance enhancing drug.
Jelkmann W
Curr Pharm Biotechnol; 2000 Jul; 1(1):11-31. PubMed ID: 11467358
[TBL] [Abstract][Full Text] [Related]
16. Effect of rHuEpo therapy in dialysis patients on endogenous erythropoietin synthesis after renal transplantation.
Fernández Lucas M; Marcén R; Villafruela J; Teruel JL; Tato A; Rivera M; Ortuño J
Nephron; 1996; 73(1):54-7. PubMed ID: 8742957
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant and early posttransplant predictors of chronic allograft nephropathy in cadaveric kidney allograft--a single-center analysis of 1112 cases.
Lietz K; Lewandowski Z; Lao M; Paczek L; Gaciong Z
Transpl Int; 2004 Feb; 17(2):78-88. PubMed ID: 14605803
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury.
Cassis P; Gallon L; Benigni A; Mister M; Pezzotta A; Solini S; Gagliardini E; Cugini D; Abbate M; Aiello S; Rocchetta F; Scudeletti P; Perico N; Noris M; Remuzzi G
Kidney Int; 2012 May; 81(9):903-18. PubMed ID: 22318420
[TBL] [Abstract][Full Text] [Related]
19. Functional erythropoietin-hepcidin axis in recombinant human erythropoietin independent haemodialysis patients.
Touzot M; Lefebvre T; Roux A; Maheas C; Ridel C; Puy H; Karim Z
Nephrology (Carlton); 2019 Jul; 24(7):751-757. PubMed ID: 30175513
[TBL] [Abstract][Full Text] [Related]
20. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
Chen JH; Mao YY; He Q; Wu JY; Lv R
Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
